NANOVIRICIDES, INC.
Developing biomimetic nanomachines as broad-spectrum drugs to neutralize viral infections.
NNVC | NYSE
Overview
Corporate Details
- ISIN(s):
- US6300873022
- LEI:
- Country:
- United States of America
- Address:
- 1 CONTROLS DRIVE, 6484 SHELTON
- Website:
- https://www.nanoviricides.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
NanoViricides, Inc. is a clinical-stage biopharmaceutical company developing a novel class of broad-spectrum antiviral drugs. The company's proprietary nanoviricide® platform technology employs biomimetic nanomachines that act as host-mimetic decoys to attack enveloped virus particles. These agents are designed to bind to a virus, mimicking a human cell receptor, and then trap and dismantle the virus particle, effectively neutralizing it. This mechanism aims to be effective without direct immune system assistance and to create therapies that viruses cannot easily escape through mutation. The company's development pipeline targets a wide range of infections, including coronaviruses, shingles (VZV), HIV, influenza, and hemorrhagic fever viruses like Ebola and Marburg.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NANOVIRICIDES, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NANOVIRICIDES, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NANOVIRICIDES, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
